FML Forte: Potent Corticosteroid Relief for Severe Ocular Inflammation
| Product dosage: 5ml | |||
|---|---|---|---|
| Package (num) | Per flacon | Price | Buy |
| 2 | $18.49 | $36.98 (0%) | 🛒 Add to cart |
| 3 | $16.91 | $55.47 $50.74 (9%) | 🛒 Add to cart |
| 4 | $15.91 | $73.96 $63.64 (14%) | 🛒 Add to cart |
| 5 | $15.31 | $92.45 $76.54 (17%) | 🛒 Add to cart |
| 6 | $15.05 | $110.94 $90.30 (19%) | 🛒 Add to cart |
| 7 | $14.74 | $129.43 $103.20 (20%) | 🛒 Add to cart |
| 8 | $14.62 | $147.92 $116.96 (21%) | 🛒 Add to cart |
| 9 | $14.43 | $166.41 $129.86 (22%) | 🛒 Add to cart |
| 10 | $14.28
Best per flacon | $184.90 $142.76 (23%) | 🛒 Add to cart |
FML Forte (fluorometholone ophthalmic suspension) 0.1% is a high-potency topical corticosteroid formulated for the management of severe steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe. It is indicated when a robust anti-inflammatory and immunosuppressive effect is required to control significant ocular inflammation that is unresponsive to weaker steroid preparations. Its enhanced formulation delivers a concentrated therapeutic effect, targeting the underlying inflammatory cascade to reduce edema, fibrin deposition, capillary dilation, and phagocytic migration. FML Forte is a critical tool in the ophthalmologist’s armamentarium for preserving visual function and ocular integrity in the face of aggressive inflammatory disease.
Features
- High-potency fluorometholone suspension at 0.1% concentration
- Lipophilic formulation for enhanced corneal penetration
- Preservative: benzalkonium chloride 0.004%
- Supplied in a sterile, opaque white, plastic ophthalmic dispenser bottle (2.5 mL, 5 mL, 10 mL)
- pH adjusted to approximate the tear film (approximately 7.0)
- Viscosity-enhanced to prolong corneal contact time
Benefits
- Rapidly suppresses severe inflammatory responses, reducing pain, photophobia, and blurred vision associated with ocular inflammation.
- Helps prevent tissue damage and scarring that can lead to permanent vision impairment.
- Facilitates a quicker return to baseline ocular comfort and function by effectively controlling the underlying inflammatory mediators.
- Provides a potent therapeutic option for conditions where standard-strength corticosteroids have proven insufficient.
- Aids in the management of post-operative inflammation following ocular surgery, promoting optimal healing outcomes.
Common use
FML Forte is prescribed for the short-term treatment of severe steroid-responsive inflammatory conditions of the eye. Its common uses include, but are not limited to, allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis (when the inherent hazard of steroid use is accepted to obtain a diminution in edema and inflammation), and the prevention of corneal neovascularization post-chemical, thermal, or radiation burns. It is also used to manage post-operative inflammation following surgical procedures such as cataract extraction and refractive surgery.
Dosage and direction
Shake the bottle well before each use. The dosage of FML Forte must be individualized based on the severity of the inflammatory condition.
- Initial Treatment: Instill 1 to 2 drops into the conjunctival sac of the affected eye(s) every 1 to 2 hours during the day and every 2 hours during the night until a satisfactory clinical response is obtained.
- Maintenance Dose: After a favorable response is observed, reduce dosage to 1 drop 2 to 4 times daily. The frequency of administration should be decreased gradually, consistent with established clinical principles for corticosteroid tapering.
- Treatment Duration: Treatment should not be discontinued abruptly. The duration of treatment will vary but typically should not exceed 2 weeks for most conditions. Prolonged use requires careful slit-lamp monitoring and tonometry.
- To prevent contamination of the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. Keep the bottle tightly closed when not in use.
Precautions
- Prolonged Use: May increase the risk of elevated intraocular pressure (IOP), which may result in glaucoma, optic nerve damage, and defects in the visual fields. It may also increase the susceptibility to secondary ocular infections from fungi or viruses.
- Steroid Response: Monitor IOP in all patients, even though a steroid response is less common with fluorometholone than with dexamethasone. Patients should be re-evaluated if the clinical signs and symptoms do not improve after 2 days.
- Perforation: Use with extreme caution in patients with corneal thinning or those with a history of corneal ulceration, as perforation has been known to occur with the use of topical corticosteroids.
- Cataracts: Posterior subcapsular cataract formation has been reported with prolonged use of corticosteroids.
- Contact Lenses: Patients should be advised not to wear contact lenses during the course of treatment with FML Forte.
- Bacterial Infection: If an infection does not respond promptly to appropriate therapy, discontinue use until the infection has been adequately controlled.
Contraindications
FML Forte is contraindicated in:
- Most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella.
- Mycobacterial infection of the eye.
- Fungal diseases of the ocular structures.
- Hypersensitivity to any component of this medication (fluorometholone, benzalkonium chloride, or other ingredients).
- Purulent, untreated ocular infections.
Possible side effect
The following adverse reactions may occur, listed by system:
- Ocular: Elevated intraocular pressure (IOP) with possible development of glaucoma and infrequent optic nerve damage; posterior subcapsular cataract formation; secondary ocular infection from fungi or viruses liberated from ocular tissues; corneal perforation in thin corneas; transient stinging or burning upon instillation; blurred vision; ocular discomfort/irritation; foreign body sensation; conjunctival hyperemia; punctate keratitis; mydriasis; ptosis.
- Non-ocular: Systemic effects are rare with topical use but are possible, especially with prolonged use, and may include manifestations of hypercortisolism.
Drug interaction
- Although minimal systemic absorption occurs, potential interactions exist with other systemic corticosteroids a patient may be taking.
- Inform your physician of all medications you are using, including prescription, over-the-counter, vitamins, and herbal products.
Missed dose
If a dose is missed, instill it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with your regular dosing schedule. Do not instill a double dose to make up for a missed one.
Overdose
Topical overdose of FML Forte is unlikely to cause acute, life-threatening symptoms. The bottle contains a relatively small amount of medication. If accidentally ingested, seek medical attention or contact a Poison Control Center immediately. Ocular overdose may be flushed from the eye(s) with warm tap water.
Storage
- Store at controlled room temperature 15°-30°C (59°-86°F).
- Protect from freezing and direct light.
- Keep the bottle tightly closed when not in use.
- Discard the bottle and any remaining medication 28 days after first opening to prevent contamination and potential infection. Write the discard date on the bottle label when you open it.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
- “As an ophthalmologist with over 20 years of experience, FML Forte is my go-to for severe anterior uveitis flares. Its potency is reliable, and I find the steroid response profile more favorable than that of dexamethasone for many of my patients.” – Dr. E. Vance, MD
- “Prescribed after a severe case of allergic conjunctivitis that wasn’t responding to loteprednol. The difference was noticeable within 24 hours. The inflammation and discomfort reduced significantly. Follow-up pressure checks were normal.” – Patient M.T.
- “An essential medication in our post-operative care protocol for high-risk cataract patients. It effectively controls inflammation without the significant IOP spikes we sometimes see with other agents.” – Surgical RN, Ambulatory Center
- “The burning sensation upon application is more pronounced than with other drops, but the therapeutic effect for my persistent keratitis was worth it. My vision cleared up within a few days of starting treatment.” – Patient J.K.